Source: Blood [Blood] 2021 Jul 22; Vol. 138 (3), pp. 273-282.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older.

Authors : Bashey ZA; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, 30342, USA.; Zhang X

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*methods ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

Source: Bone marrow transplantation [Bone Marrow Transplant] 2018 Jun; Vol. 53 (6), pp. 756-763. Date of Electronic Publication: 2018 Mar 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.

Authors : Solomon SR; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, Georgia. Electronic address: .; Sanacore M

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*administration & dosage ; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; Hematologic Neoplasms/Hematologic Neoplasms/Hematologic Neoplasms/*therapy

Source: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2014 Nov; Vol. 20 (11), pp. 1828-34. Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.

Authors : Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.; Zhang MJ

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/pathology; Humans

Source: Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 7007-7016.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors.

Authors : Bashey A; Blood and Marrow Transplant Program and Leukemia Program, Northside Hospital Cancer Institute, Atlanta, GA.; Zhang X

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/pathology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology

Source: Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 3816-3823.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.

Authors : Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University, Boston, MA.; Solomon SR

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Adult

Source: Blood [Blood] 2023 Apr 06; Vol. 141 (14), pp. 1675-1684.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).

Authors : Solh MM; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA. .; Farnham C

Subjects: Photopheresis*/Photopheresis*/Photopheresis*/methods ; Graft vs Host Disease* ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Feb; Vol. 58 (2), pp. 168-174. Date of Electronic Publication: 2022 Nov 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Inferences for current chronic graft-versus-host-disease free and relapse free survival.

Authors : Zhang X; Center for Clinical and Translational Sciences, The University of Texas Health Science Center at Houston, Houston, TX, US. .; Solomon SR

Subjects: Graft vs Host Disease* ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Bronchiolitis Obliterans Syndrome*

Source: BMC medical research methodology [BMC Med Res Methodol] 2022 Dec 13; Vol. 22 (1), pp. 318. Date of Electronic Publication: 2022 Dec 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL.

Authors : Abramson JS; Lymphoma Program, Massachusetts General Hospital Cancer Center, Boston, MA.; Johnston PB

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large B-Cell, Diffuse*; Adult

Source: Blood advances [Blood Adv] 2022 Dec 13; Vol. 6 (23), pp. 5969-5979.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.

Authors : Solomon SR; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia. Electronic address: .; Brown S

Subjects: Hematopoietic Stem Cell Transplantation* ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy; Bendamustine Hydrochloride/Bendamustine Hydrochloride/Bendamustine Hydrochloride/therapeutic use

Source: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Aug; Vol. 28 (8), pp. 486.e1-486.e7. Date of Electronic Publication: 2022 May 20.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي